FathomX is a Digital Health AI spin-off company from the National University of Singapore and National University Health System and is the brainchild of Prof Mikael Hartman (Breast Cancer Surgeon at NUH) and Prof Feng Meng Ling (Assistant Professor at the Saw Swee Hock School of Public Health). Our flagship product, FxMammo, is an AI Assistant that significantly improves the screening procedure for mammograms by reducing the false positive/negative rates and enhancing the clinical workflow by reducing the time taken to assess a screen as well as the number of radiologists required per screen. Our algorithm was based off over 3 years of research at NUS and we have recently published on the prestigious AAAI Workshop and Jama Open Network Journal. We are also a portfolio company of the MedTech JUMPStart Program.

FathomX’s unique AI Model for mammogram started out in a global competition - The Dream Challenge organised by the United States’ Whitehouse. As the top Asian team in the global competition that featured more than 100 participants from around the world, the founders decided to spin-off the company with the support of NUS Enterprise. From the time of the competition, the AI model has also progressed tremendously in its predictive accuracy. Refinement and users’ preferences were also incorporated into the software and continuously upgraded to meet differing and progressing needs. Within two years of incorporation, the company has secured several research collaborations and commercial partnerships with major hospitals, industry partners, government agencies, infrastructure partners and integration partners from various regions around the world including Singapore, Taiwan, Japan, Australia, Hong Kong, Malaysia and Thailand.